Peripheral artery disease is a common disorder and a major cause of morbidity and mortality
worldwide. Therapy is directed at reducing the risk of major adverse cardiovascular events …

Skeletal muscle is among the most age-sensitive tissues in mammal organisms. Significant
changes in its resident stem cells (ie, satellite cells, SCs), differentiated cells (ie, myofibers) …

Whether bone marrow modulates systemic metabolism remains unknown. Our recent study
suggested that myeloid-derived growth factor (MYDGF) improves insulin resistance. Here …

Whether bone marrow modulates systemic metabolism remains unknown. Here, we found
that (i) myeloid cell–specific myeloid-derived growth factor (MYDGF) deficiency exacerbated …

Tissue engineering heart valve (TEHV) offers great potential to overcome the limitations of
commercial artificial valves used in clinical practice as a permanent prosthetic valve …

Aims/hypothesis Myeloid-derived growth factor (MYDGF), mainly secreted by bone marrow-
derived cells, has been known to promote glucagon-like peptide-1 production and improve …

Organ injury stimulates the formation of new capillaries to restore blood supply raising
questions about the potential contribution of neoangiogenic vessel architecture to the …

Abstract Growth differentiation factor 11 (GDF11) and myostatin (MSTN) are closely related
TGFβ family members that are often believed to serve similar functions due to their high …

Angiogenesis plays a central role in human physiology from reproduction and fetal
development to wound healing and tissue repair/regeneration. Clinically relevant therapies …

Stem cells and progenitor cells have been identified as potential new therapeutic options for
severe limb ischemia to induce angiogenesis, and hyaluronic acid (HA) is commonly …